Forschung & Innovation
Publikationen
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
PMU Autor*innen
Karl Wurstbauer, Heinz Deutschmann, Franz Zehentmayr, Michael Studnicka, Felix Sedlmayer
Alle Autor*innen
Karl Wurstbauer, Heinz Deutschmann, Karin Dagn, Peter Kopp, Franz Zehentmayr, Bernd Lamprecht, Peter Porsch, Birgit Wegleitner, Michael Studnicka, Felix Sedlmayer
Fachzeitschrift
RADIATION ONCOLOGY
Kurzfassung
Keywords
TERM-FOLLOW-UP, PHASE-III TRIAL, CELL LUNG-CANCER, INDUCTION CHEMOTHERAPY, THORACIC RADIOTHERAPY, ONCOLOGY-GROUP, I/II TRIAL, STAGES I, CONCURRENT, ESCALATION